TOP STORIES

• BUSINESS Japan’s Top 3 Drug Makers Join Forces on Biomarker Research
  May 24, 2016

• BUSINESS Generic Makers Enjoy Revenue Rises as Govt Tailwinds Continue: Jiho Tally
  May 23, 2016

• REGULATORY Clinical Research Bill to Make It Easier for Companies to Provide Unapproved Drugs for Clinical Programs: LDP Lawmaker
  May 20, 2016

• REGULATORY Pricy Meds Again a Hot Topic at Chuikyo, MHLW Set to Launch Concrete Discussions
  May 19, 2016

• REGULATORY Chuikyo OKs 16 APIs for Listing on May 25, Novartis’s Melanoma Combo Gets 45% Price Premium
  May 18, 2016

• BUSINESS Top 8 Japan Drug Makers Relish 2.6-Fold Operating Profit Jump on Global Brands
  May 17, 2016

• BUSINESS As Tagrisso Launch Nears, AZ Pushes Stringent Prerequisites for Facilities, Doctors to Ensure Safety
  May 17, 2016

• ACADEMIA MHLW Study Group Drafting Guidelines for Assessing Cost-Effectiveness of Vaccines Proposed for Inclusion in Public Vaccination Programs
  May 16, 2016

• BUSINESS Daiichi Sankyo Sees 7.3% Sales Rise, but Girding for FY2016 Dip on Olmesartan Cliff
  May 13, 2016

• BUSINESS Ono Delivers Record Sales on Buoyant Opdivo, FY2016 Outlook Tops 250 Billion Yen
  May 12, 2016

• BUSINESS AZ Set to Double Japan Sales by 2020 on Cancer Meds, No Patent Cliff in Sight: Local Pres. Baertschi
  May 11, 2016

• REGULATORY Pharmacists Can Make Big Contribution to Health Finances by Reducing Drug Waste: MHLW Study Group Chief
  May 10, 2016

• ACADEMIA Use Patient Registries for Orphan, Intractable Diseases First: MHLW Study Group Chief
  May 9, 2016

• BUSINESS Sales Rep Survey - Part 2: Drug Makers Exploring Viable Roles amid Govt’s Community-Based Care Initiative
  May 6, 2016

• BUSINESS Sales Rep Survey - Part 1: Number of Reps at Foreign Drug Makers Declines Sharply; Down by 330 at GSK
  May 2, 2016

• BUSINESS 53 Drug Makers Hire 200 Less New Grads in FY2016, Japan Firms See Hefty Drop: Jiho Tally
  April 28, 2016

• BUSINESS Nogimori to Bow Out as Astellas Chairman
  April 28, 2016

• REGULATORY Chuikyo OKs 7 Drugs Subject to Cost-Effective Review; Re-Pricing to Be Conducted in 2018
  April 27, 2016

• BUSINESS Harvoni Most Prescribed Drug at Acute Hospitals in October-December
  April 27, 2016

• BUSINESS Novartis Looks to Harness Big Data for Indication Expansions: Global Medical Chief
  April 26, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 178
• 179
• 180
• 181
• 182
• 183
• 184
• 185
• 186
• …
• Next ›
• 最終 »